Swab And Viral Transport Medium Market
完整報告名稱與涵蓋範圍
Swab And Viral Transport Medium Market Size, Share & Trends Analysis Report By Product (Swab Type (Nasal Swabs, Nasopharyngeal Swabs and Throat Swabs), Transport Medium), By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031
報告摘要
Industry analysis indicates the Swab And Viral Transport Medium Market globally will progress at a 6.47% CAGR during 2024–2031.
Swab And Viral Transport Medium encompasses challenges.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Swab and Viral Transport Medium Market Snapshot
Chapter 4. Global Swab and Viral Transport Medium Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Penetration & Growth Prospect Mapping
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. COVID 19 Impact Analysis
4.9. Clinical Trial/Pipeline Analysis for Viral Disease Diagnosis 2020
Chapter 5. Market Segmentation 1: Products Estimates & Trend Analysis
5.1. Products & Market Share, 2019 & 2031
5.2. Market Size (Value) & Forecasts and Trend Analyses, 2019 to 2031 for the following Products:
5.2.1. Swab Type
5.2.1.1. Nasal Swabs
5.2.1.2. Nasopharyngeal Swabs
5.2.1.3. Throat Swabs
5.2.2. Transport Medium
Chapter 6. Market Segmentation 2: Applications & Trend Analysis
6.1. Applications & Market Share, 2019 & 2031
6.2. Market Size (Value)& Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Viral Infection Diagnosis
6.2.1.1. COVID-19
6.2.1.2. Influenza
6.2.1.3. Herpes Simplex Virus
6.2.1.4. Varicella-zoster Virus
6.2.2. Others
Chapter 7. Market Segmentation 3: End-Users & Trend Analysis
7.1. End-Users & Market Share, 2019 & 2031
7.2. Market Size (Value)& Forecasts and Trend Analyses, 2019 to 2031 for the following End-Users
7.2.1. Hospitals & Clinics
7.2.2. Microbiology Laboratories
7.2.3. Diagnostic Laboratories
7.2.4. Others
Chapter 8. Swab and Viral Transport Medium Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
8.1.2. North America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Applications, 2024-2031
8.1.3. North America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.1.4. North America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
8.2.2. Europe Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Applications, 2024-2031
8.2.3. Europe Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.2.4. Europe Swab and Viral Transport Medium Market Revenue (US$ Million) by Country, 2024-2031
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
8.3.2. Asia Pacific Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Applications, 2024-2031
8.3.3. Asia Pacific Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.3.4. Asia Pacific Swab and Viral Transport Medium Market Revenue (US$ Million) by Country, 2024-2031
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
8.4.2. Latin America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Applications, 2024-2031
8.4.3. Latin America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.4.4. Latin America Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts Estimates and Forecasts by Products, 2024-2031
8.5.2. MEA Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Applications, 2024-2031
8.5.3. MEA Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.5.4. MEA revenue Swab and Viral Transport Medium Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.4.1. South Africa
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific
9.2.2. Becton
9.2.3. Dickinson and Company
9.2.4. MWE
9.2.5. Titan Biotech Ltd
9.2.6. COPAN Diagnostics Inc.
9.2.7. MANTACC
9.2.8. Puritan Medical Products
9.2.9. YOCON Biology
9.2.10. Trinity Biotech
9.2.11. VIRCELL S.L.
9.2.12. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們